thymidine has been researched along with Lactic Acidosis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Telbivudine can cause severe side effects, including myositis, neuritis, rhabdomyolysis, and lactic acidosis." | 8.95 | Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. ( Chen, Z; Deng, M; Deng, Q; Deng, X; Li, D; Qiu, X; Yu, Z; Zheng, J, 2017) |
| "All oral nucleoside analogues against hepatitis B virus, with an exception of telbivudine, have been reported causing lactic acidosis (LA)." | 8.89 | Lactic acidosis during telbivudine treatment for HBV: a case report and literature review. ( Hu, P; Huang, XY; Jin, JL; Lu, JH; Luo, SS; Weng, XH; Zhang, JM, 2013) |
| "9% of patients on telbivudine treatment were reported to develop severe elevation of serum creatine phosphokinase (CPK) levels, but related clinical disease, like lactic acidosis (LA) and rhabdomyolysis (RM) were rare." | 7.88 | Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B. ( Hu, YK; Huang, YX; Jin, JL; Ying, Y; Zhang, JM; Zhang, WH, 2018) |
| "To evaluate the prevalence, outcome and possible risk factors for hyperlactataemia and lactic acidosis in HIV-positive persons receiving antiretroviral therapy." | 7.71 | Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. ( Asboe, D; Datta, D; Gazzard, BG; Mandalia, S; Morlese, J; Moyle, GJ, 2002) |
| "Telbivudine can cause severe side effects, including myositis, neuritis, rhabdomyolysis, and lactic acidosis." | 4.95 | Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. ( Chen, Z; Deng, M; Deng, Q; Deng, X; Li, D; Qiu, X; Yu, Z; Zheng, J, 2017) |
| "All oral nucleoside analogues against hepatitis B virus, with an exception of telbivudine, have been reported causing lactic acidosis (LA)." | 4.89 | Lactic acidosis during telbivudine treatment for HBV: a case report and literature review. ( Hu, P; Huang, XY; Jin, JL; Lu, JH; Luo, SS; Weng, XH; Zhang, JM, 2013) |
| "9% of patients on telbivudine treatment were reported to develop severe elevation of serum creatine phosphokinase (CPK) levels, but related clinical disease, like lactic acidosis (LA) and rhabdomyolysis (RM) were rare." | 3.88 | Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B. ( Hu, YK; Huang, YX; Jin, JL; Ying, Y; Zhang, JM; Zhang, WH, 2018) |
| "To evaluate the prevalence, outcome and possible risk factors for hyperlactataemia and lactic acidosis in HIV-positive persons receiving antiretroviral therapy." | 3.71 | Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. ( Asboe, D; Datta, D; Gazzard, BG; Mandalia, S; Morlese, J; Moyle, GJ, 2002) |
| "Increased risk of lactic acidosis has also been described for those with impaired liver and renal function taking entecavir." | 2.50 | Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment. ( Fung, J; Lai, CL; Seto, WK; Yuen, MF, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, J | 1 |
| Deng, M | 1 |
| Qiu, X | 1 |
| Chen, Z | 1 |
| Li, D | 1 |
| Deng, X | 1 |
| Deng, Q | 1 |
| Yu, Z | 1 |
| Ying, Y | 1 |
| Hu, YK | 1 |
| Jin, JL | 2 |
| Zhang, JM | 2 |
| Zhang, WH | 1 |
| Huang, YX | 1 |
| Hu, P | 1 |
| Lu, JH | 1 |
| Luo, SS | 1 |
| Huang, XY | 1 |
| Weng, XH | 1 |
| Fung, J | 1 |
| Seto, WK | 1 |
| Lai, CL | 1 |
| Yuen, MF | 1 |
| Moyle, GJ | 1 |
| Datta, D | 1 |
| Mandalia, S | 1 |
| Morlese, J | 1 |
| Asboe, D | 1 |
| Gazzard, BG | 1 |
3 reviews available for thymidine and Lactic Acidosis
| Article | Year |
|---|---|
Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature.
Topics: Acidosis, Lactic; Adult; Antiviral Agents; Asian People; Hepatitis B, Chronic; Humans; Male; Multipl | 2017 |
Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.
Topics: Acidosis, Lactic; Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Male; Mitochondrial Disease | 2013 |
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
Topics: Acidosis, Lactic; Adenine; Administration, Oral; Antiviral Agents; Arabinofuranosyluracil; Dose-Resp | 2014 |
2 other studies available for thymidine and Lactic Acidosis
| Article | Year |
|---|---|
Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.
Topics: Acidosis, Lactic; Antiviral Agents; DNA Polymerase gamma; Drug Therapy, Combination; Hepatitis B, Ch | 2018 |
Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Cross-Sectional Studies; Didanosine; Dideoxynucleosides; F | 2002 |